Silva Francisco has filed 8 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 11719 shares of BioRestorative Therapies, Inc. ($BRTX) on October 06, 2025.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 6, 2025 | BioRestorative Therapies, Inc. | $BRTX | Silva Francisco | VP of Research and Development | A | Comon Stock | 11719 | $1.60 | 171,384.0000 | 9,116,172 | 7.34% | 0.13% |
| Oct. 6, 2025 | BioRestorative Therapies, Inc. | $BRTX | Silva Francisco | VP of Research and Development | A | Warrant | 11719 | $0.00 | 11,719.0000 | 9,116,172 | 9999.99% | 0.13% |
| Feb. 14, 2025 | BioRestorative Therapies, Inc. | $BRTX | Silva Francisco | VP of Research and Development | A | Stock Option | 768979 | $0.00 | 1,606,082.0000 | 7,763,932 | 91.86% | 9.90% |
| April 9, 2024 | BioRestorative Therapies, Inc. | $BRTX | Silva Francisco | VP of Research and Development | P | Common Stock | 6600 | $1.25 | 167,895.0000 | 4,218,347 | 4.09% | 0.16% |
| April 8, 2024 | BioRestorative Therapies, Inc. | $BRTX | Silva Francisco | VP of Research and Development | P | Common Stock | 1232 | $1.17 | 161,295.0000 | 4,218,347 | 0.77% | 0.03% |
| April 8, 2024 | BioRestorative Therapies, Inc. | $BRTX | Silva Francisco | VP of Research and Development | P | Common Stock | 476 | $1.13 | 160,063.0000 | 4,218,347 | 0.30% | 0.01% |
| March 18, 2024 | BioRestorative Therapies, Inc. | $BRTX | Silva Francisco | VP of Research and Development | F | Common Stock | 17193 | $1.39 | 159,587.0000 | 4,218,347 | 9.73% | 0.41% |
| Feb. 13, 2024 | BioRestorative Therapies, Inc. | $BRTX | Silva Francisco | VP of Research and Development | A | Stock Option | 394737 | $0.00 | 837,116.0000 | 4,218,347 | 89.23% | 9.36% |